Figure 2.
Persistent alterations in the immunoregulatory landscape at M12 after allo-HSCT. (A-B) Frequencies of cell metaclusters (FlowSOM) among PBMCs from patients at M12 after transplantation were compared with those of healthy donors. Six of 18 cell MCs were significantly decreased (A) and 1 was increased (B). Mann-Whitney tests: *P < .05; **P < .01; ***P < .001; ****P < .0001. (C) Each immune cell subset (percentage of cell subset among total CD45+ live cells or among a parent cell subset when indicated by "/subset") assessed by classic manual gating was also compared between patients at M12 and healthy donors. Significant (Mann-Whitney test) parameters are annotated. (D) Altered expression of immunoregulatory molecules in indicated T- and NK-cell subsets. Circles indicate significantly increased (red) or decreased (gray) median expression of the regulatory molecules in patients at M12 after HSCT, compared with healthy donors.

Persistent alterations in the immunoregulatory landscape at M12 after allo-HSCT. (A-B) Frequencies of cell metaclusters (FlowSOM) among PBMCs from patients at M12 after transplantation were compared with those of healthy donors. Six of 18 cell MCs were significantly decreased (A) and 1 was increased (B). Mann-Whitney tests: *P < .05; **P < .01; ***P < .001; ****P < .0001. (C) Each immune cell subset (percentage of cell subset among total CD45+ live cells or among a parent cell subset when indicated by "/subset") assessed by classic manual gating was also compared between patients at M12 and healthy donors. Significant (Mann-Whitney test) parameters are annotated. (D) Altered expression of immunoregulatory molecules in indicated T- and NK-cell subsets. Circles indicate significantly increased (red) or decreased (gray) median expression of the regulatory molecules in patients at M12 after HSCT, compared with healthy donors.

Close Modal

or Create an Account

Close Modal
Close Modal